ACRIVON THERAPEUTICS, INC. SHARES OF COMMON STOCK, PAR VALUE $0.001 PER SHARE SALES AGREEMENTSales Agreement • December 1st, 2023 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations • New York
Acrivon Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“TD Cowen”), as follows:
